Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure

Circulation

Volumn 107, Issue 2, 2003, Pages 294-299

  Mancini, Donna M ^a,b   Katz, Stuart D ^a   Lang, Chim C ^a   LaManca, John ^a   Hudaihed, Alhakam ^a   Androne, Ana Silvia ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b Division of Circulatory Physiology   (United States)

Author keywords

Exercise; Growth substances; Heart failure

Indexed keywords

ERYTHROPOIETIN; PLACEBO;

ADULT; AGED; ANAEROBIC METABOLISM; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG MECHANISM; EXERCISE; FEMALE; FOREARM; HEART FAILURE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; MALE; MEMBRANE STEADY POTENTIAL; NEAR INFRARED SPECTROSCOPY; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHYSICAL PERFORMANCE; PLASMA VOLUME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; VASCULAR RESISTANCE; VASODILATATION;

ANEMIA; CHRONIC DISEASE; ERYTHROCYTE VOLUME; ERYTHROPOIETIN; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOREARM; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PLASMA VOLUME; PROSPECTIVE STUDIES; QUALITY OF LIFE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VASODILATION;

EID: 0037458127     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000044914.42696.6A     Document Type: Article

References (27)

1. Goodnough LT, Monk TG, Andriole GL. Erythropoietin therapy. N Engl J Med. 1997;336:933-938.
2. Silverberg DS. Wexler D. Blum et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-1744.
3. Means RT. Advances in the anemia of chronic disease. Int J Hematol. 1999;70:r7-r12.
4. Anand IS, Ferrari R, Kalra GS, et al. Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989;80:299-305.
5. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775-1780.
6. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71:1106-1107.
7. Feldschuh J, Enson Y. Prediction of normal blood volume. Circulation. 1977;56:605-612.
8. McCully K, Hamaoka T. Near-infrared spectroscopy: what can it tell us about oxygen saturation in skeletal muscle. Exercise Sports Sci Rev. 2000;28:123-127.
9. Cohen-Solal A, Laperche T, Morvan D, et al. Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Circulation. 1995;91:2924-2932.
10. Katz SD, Krum H, Khan T, et al. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol. 1996;28:585-590.
11. Haber HL, Leavy JA, Kessler PD, et al. The erythrocyte sedimentation rate in congestive heart failure. N Engl J Med. 1991;324:353-358.
12. Rich MW, Beckham C, Wittenberg CL, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-1195.
13. Ghali JK, Kadaika S, Cooper R, et al. Precipitating factors leading to decompensation of heart failure: traits among urban blacks. Arch Intern Med. 1988;148:2013-2016.
14. Al-Ahmad A, Rand WM, Manjunth G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955-962.
15. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kid Dis. 1999;34:125-134.
16. Silverberg DS, Iaina A, Wexler D, et al. The pathological consequences of anemia. Clin Lab Haem. 2001;23:1-6.
17. Volpe M, Tritto C, Testa U, et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol. 1994;74:468-473.
18. Kumagai J, Yorioka N, Kawanishi H, et al. Relationship between erythropoietin and chronic heart failure in patients on chronic hemodialysis. J Am Soc Nephrol. 1999;10:2407-2411.
19. Maschio G. Erythropoietin and systemic hypertension. Nephrol Dial Transplant. 1995;10(suppl 2):74-79.
20. Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kid Dis. 1995;26:4-46.
21. Adamson JW, Vapnek D. Recombinant erythropoietin to improve athletic performance. N Engl J Med. 1991;324:698-699.
22. Ekblom B, Berglund B. Effects of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports. 1991;1:88-93.
23. McMahon LP, McKenna MJ, Sangkabuttra T, et al. Physical performance and associated electrolyte changes after hemoglobin normalization: a comparative study in haemodialysis patients. Nephrol Dial Transplant. 1999;14:1182-1187.
24. Kuriyama S, Hopp L, Yoshida H, et al. Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients. Am J Hypertens. 1996;9:426-431.
25. Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584-590.
26. Macdougall IC, Ritz E. The normal hematocrit trial in dialysis patients with cardiac disease: are we any less confused about target hemoglobin? Nephrol Dial Transplant 1998;13:3030-3033.
27. Ma JZ, Ebben J, Xia H, et al. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol. 1999;10:610-619.